Peroxisome proliferator-activated receptor γ:: the more the merrier?

被引:53
|
作者
Argmann, CA
Cock, TA
Auwerx, J
机构
[1] Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France
[2] Genopole Strasbourg, Inst Clin Souris, F-67404 Illkirch Graffenstaden, France
关键词
atherosclerosis; longevity and bone; metabolism; mouse models; PPAR gamma;
D O I
10.1111/j.1365-2362.2005.01456.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The consequence of activating the nuclear hormone receptor, peroxisome proliferator-activated receptor gamma (PPARgamma), which coordinates adipocyte differentiation, validates the concept, 'you are what you eat'. Excessive caloric intake leads to fat formation if the energy from these nutrients is not expended. However, this evolutionary adaptation to store energy in fat, which can be released under the form of fatty acids, potent PPARgamma agonists, has become a disadvantage in today's affluent society as it results in numerous metabolic imbalances, collectively known as the metabolic syndrome. With the surge of human and genetic studies on PPARgamma function, the limitations to the benefits of PPARgamma signalling have been realized. It is now evident that the most effective strategy for resetting the balance of this thrifty gene is through its modulation rather than full activation, with the goal to improve glucose homeostasis while preventing adipogenesis. Finally, as more PPARgamma targeted pathways are revealed such as bone homeostasis, atherosclerosis and longevity, it is most certain that the PPARgamma thrifty gene hypothesis will evolve to incorporate these.
引用
收藏
页码:82 / 92
页数:11
相关论文
共 50 条
  • [1] Peroxisome proliferator-activated receptor γ and atherosclerosis
    Marx, N
    [J]. CURRENT HYPERTENSION REPORTS, 2002, 4 (01) : 71 - 77
  • [2] Peroxisome proliferator-activated receptor γ and cancers
    Koeffler, HP
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (01) : 1 - 9
  • [3] Peroxisome proliferator-activated receptor agonists
    Willson, TM
    Wahli, W
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (02) : 235 - 241
  • [4] Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
    Nishida, K.
    Kunisada, T.
    Shen, Z. N.
    Kadota, Y.
    Hashizume, K.
    Ozaki, T.
    [J]. PPAR RESEARCH, 2008, 2008
  • [5] Peroxisome proliferator-activated receptor γ and atherosclerosis
    Nikolaus Marx
    [J]. Current Hypertension Reports, 2002, 4 : 71 - 77
  • [6] Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
    Jean-Charles Fruchart
    [J]. Cardiovascular Diabetology, 12
  • [7] Peroxisome proliferator-activated receptor α-independent peroxisome proliferation
    Zhang, Xiuguo
    Tanaka, Naoki
    Nakajuna, Takero
    Kamijo, Yuji
    Gonzalez, Frank J.
    Aoyama, Toshifumi
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 346 (04) : 1307 - 1311
  • [8] Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells
    Wang, D.
    Ning, W.
    Xie, D.
    Guo, L.
    DuBois, R. N.
    [J]. ONCOGENE, 2012, 31 (08) : 1013 - 1023
  • [9] Inflammation in diabetes mellitus:: Role of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ agonists
    Libby, Peter
    Plutzky, Jorge
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (4A): : 27B - 40B
  • [10] Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells
    D Wang
    W Ning
    D Xie
    L Guo
    R N DuBois
    [J]. Oncogene, 2012, 31 : 1013 - 1023